Evidence map›Paper›PMID 25574344›Full record

ReviewMethodist DeBakey cardiovascular journal

Nuclear cardiology: 2014 innovations and developments.

John J Mahmarian, SuMin Chang, Faisal Nabi

Open access · diamondAbstract readReview
In one paragraph

Review in Methodist DeBakey cardiovascular journal. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

John J MahmarianHouston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas.
SuMin ChangHouston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas.
Faisal NabiHouston Methodist DeBakey Heart & Vascular Center, Houston Methodist Hospital, Houston, Texas.
Houston Methodist · USMethodist Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nuclear cardiac imaging is acknowledged as a robust technique for clinically assessing patients with a wide spectrum of cardiac illnesses. Recent technical, radiotracer, and stressor advancements continue to expand the role of nuclear cardiology for the accurate diagnosis and prognostication of patients with known or suspected coronary artery disease. The introduction of I-123 MIBG represents another advance for assessing risk in patients with congestive heart failure and depressed left ventricular (LV) function. Software and hardware innovations and recent shifts in acquisition protocols have greatly improved image quality, reduced cost and radiation exposure, and continue to promote patient and physician satisfaction. The following article will highlight recent achievements in the field that continue to foster a patient-centered imaging approach.

Indexed as

Diffusion of InnovationCoronary CirculationEquipment DesignHeart DiseasesHemodynamicsHumansMyocardial Perfusion ImagingPredictive Value of TestsPrognosisRadiopharmaceuticalsSeverity of Illness IndexSoftware DesignTomography, Emission-Computed, Single-PhotonRadiopharmaceuticalsimage acquisitioniodine I 123 mIBGnuclear cardiologypharmacological stressor agentsradionuclide tracers

Identifiers

PMID25574344
PMCPMC4280241
OpenAlexW2088880739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.